24 Recruiting Studies Using Fianlimab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Fianlimab
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
📍 Clermont Oncology Center — Clermont, Florida
Resectable Non-small Cell Lung Cancer
View Study & Checklist ➔Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
Prostate Cancer
View Study & Checklist ➔Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Non-small Cell Lung Cancer
View Study & Checklist ➔Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
📍 UC San Diego — La Jolla, California
Melanoma
View Study & Checklist ➔A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
📍 UC San Diego — La Jolla, California
Melanoma
View Study & Checklist ➔A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
📍 Arizona Clinical Research Center — Tucson, Arizona
Advanced Non-Small Cell Lung Cancer
View Study & Checklist ➔A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
📍 Arizona Clinical Research Center — Tucson, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma
📍 M.D. Anderson Cancer Center — Houston, Texas
Melanoma
View Study & Checklist ➔Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma
📍 Chao Family Comprehensive Cancer Center University of California, Irvine — Orange, California
Melanoma (Skin)
View Study & Checklist ➔A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
📍 The University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
Squamous Cell Carcinoma
View Study & Checklist ➔A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Nasopharyngeal Carcinoma
View Study & Checklist ➔A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activites) — Basking Ridge, New Jersey
Renal Cell Carcinoma
View Study & Checklist ➔Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
📍 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
Colorectal Cancer
View Study & Checklist ➔Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
📍 University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma
Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
📍 Georgetown University — Washington D.C., District of Columbia
Advanced Renal Cell Carcinoma (aRCC)
View Study & Checklist ➔A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
Melanoma
View Study & Checklist ➔Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
📍 The University of Alabama at Birmingham — Birmingham, Alabama
Ovarian Cancer
View Study & Checklist ➔Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
Locally Advanced Melanoma
View Study & Checklist ➔Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
📍 Montefiore Einstein Comprehensive Cancer Center (MECCC) — The Bronx, New York
NSCLC
View Study & Checklist ➔Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
📍 Columbia University Irving Medical Center/ New York Presbyterian Hospital — New York, New York
Bladder Cancer
View Study & Checklist ➔A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
📍 Scripps Clinic Torrey Pines — La Jolla, California
Multiple Myeloma
View Study & Checklist ➔Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Lung Non-Small Cell Carcinoma
View Study & Checklist ➔A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
📍 Cedars-Sinai Medical Center — Los Angeles, California
Advanced Melanoma
View Study & Checklist ➔Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
📍 Johns Hopkins SKCCC — Baltimore, Maryland
Colorectal Cancer
View Study & Checklist ➔